PER
Click for more information
0.00% 8.0¢ percheron therapeutics limited

PPMD webinar

  1. mac9
    841 Posts.
    lightbulb Created with Sketch. 755
    clock Created with Sketch.
    14/06/20
    16:22
    Post #: 45212709
    I look forward to the information flow and stimulus that may occur from this webinar.

    https://www.parentprojectmd.org/eve...erapeutics-phase-ii-trial-final-data-results/

    Antisense Therapeutics recently announced that their Phase II clinical trial of ANP’s immunomodulatory therapy, ATL1102 for Duchenne in non-ambulatory patients has met its primary endpoint, confirming the safety and tolerability of ATL1102 for advancement into a Phase IIb clinical trial. Please join PPMD and Antisense as we host a webinar Wednesday, June 17 at 1 PM ET to discuss Antisense Therapeutics’ clinical program, as well as next steps in the upcoming Phase IIb trial.
    Please submit questions in advance to [email protected] (subject line: Antisense Webinar) by Monday, June 15 at 12 PM ET.
    Register >
    ANP Price at posting: 6.3¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 11  Upvote
    lightbulb Created with Sketch. 2  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NRX Noronex joins forces with South32 to look for copper in Namibia
right-arrow Created with Sketch.
DMP Domino's locks in biggest faller status on Thursday as it closes stores in Asia, Europe
right-arrow Created with Sketch.
SKC SkyCity to lose NZ$5M in 2025 over complaint closedown
right-arrow Created with Sketch.
M2R Miramar sniffs 5.48% Cu, 54.4% Pb and 73.48g/t Ag at new WA prospect
right-arrow Created with Sketch.
WGX Australian foreign investment regulators greenlight Westgold's buyout of Karora
right-arrow Created with Sketch.
ASL Andean discovers up to 4,649 AgEq through maiden drilling in Chile
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.9¢ $12.63K 158.7K

Buyers (Bids)

No. Vol. Price($)
2 66500 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 273231 2
View Market Depth
Last trade - 15.26pm 19/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.